Relisys Medical Devices Limited, an India based integrated medical device manufacturer headquartered at Hyderabad, has successfully closed an Exclusive European Representation agreement with the Netherland based 2 Spring BV. RMDL has given exclusive representative rights for its wide range of OEM products covering coronary stents, peripheral stents, PTCA catheters, SDS, Guide catheters, Dx catheters, Intracranial micro catheters, neurology catheters, nephrology catheters, semi finished components and complex medical tubing’s including multiple lumen tubing’s, braided tubing’s and catheter tubing’s, balloon tubing’s to 2 spring, who are the leading service provider to the medical device companies in Europe. The Representation of Relisys products would enable 2 springs to exploit the European OEM market in the finished devices, semi finished devices and tubings to its existing customers and medical device industry in whole of Europe. Dr. Krishna Reddy, Chairman of Relisys Medical Devices Limited announcing the agreement said, “The agreement is the first step in a strategic international marketing collaboration with Europe’s leading OEM partner. Relisys will enforce the collaboration with 2 Springs that enables us not only to exploit our finished devices but also take up contract manufacture as per the customer’s designs. The partnership with 2 spring will help us to integrate the manufacturing capabilities of Relisys to provide high quality manufacturing services for integrated solutions and get access to Europe with Relisys’ highly innovative products pipeline.” Mr. Paul MD of 2Spring said, “2 spring has been representing US companies and is now excited to work with a leading Indian device company. Mr. Tim Apples MD said that Relisys would be one of the unique companies which can offer a basket full of solutions for the device industry. We are very happy to see that Relisys had built one of the best facilities on par with international standards and are excited to work with them in the European OEM market. Mr. Badari Narayan, Managing Director of Relisys Medical Devices says “We are going to be present on global markets with innovative products in the interventional device sector with the products going in for International approvals like USFDA, CE certification. Dr. Ramakrishna Rao, Director operations commented: With the completion of the first phase of the project which included creating a world class manufacturing facility and R&D centre, the company is now concentrating on international regulatory approvals and international launch. Mr. GVV. Sarma, Director Marketing says, “The signing of the OEM European Marketing agreement adds to the recent agreement the company for marketing its finished branded products in Brazil, Turkey. He said the company is in negotiations with prospective distributors in US. Relisys Medical’s stent manufacturing division was formally inaugurated by His Excellency Dr. APJ. Abdul Kalam in June 2007 and the catheter division went on stream in December 2008.